PARK7 — Parkinsonism Associated Deglycase (DJ-1)
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">PARK7 — Parkinsonism Associated Deglycase (DJ-1)</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>PARK7</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Parkinsonism Associated Deglycase (DJ-1)</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>1p36.23</td>
</tr>
<tr>
<td class="label">NCBI Gene</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/11315" target="_blank">11315</a></td>
</tr>
<tr>
<td class="label">Ensembl</td>
<td><a href="https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000116288" target="_blank">ENSG00000116288</a></td>
</tr>
<tr>
<td class="label">OMIM</td>
<td><a href="https://omim.org/entry/602533" target="_blank">602533</a></td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/Q99497" target="_blank">Q99497</a></td>
</tr>
<tr>
<td class="label">Diseases</td>
<td>[Parkinson's Disease](/diseases/parkinsons-disease), [ALS](/diseases/als)</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Brain, Testis, Pancreas, Retina</td>
</tr>
<tr>
<th class="infobox-subheader" colspan="2">Key Mutations</th>
</tr>
<tr>
<td colspan="2" style="font-size:0.85em">L166P, D149A, E163K, M26I, E64D</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/ad" style="color:#ef9a9a">AD</a>, <a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/alzheimer's-disease" style="color:#ef9a9a">ALZHEIMER'S DISEASE</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">212 edges</a></td>
</tr>
</table>
PARK7 — Parkinsonism Associated Deglycase (DJ-1)
Pathway Diagram
Mermaid diagram (expand to render)
Overview
PARK7 (Parkinsonism Associated Deglycase), also known as DJ-1, is a gene located on chromosome 1p36.23 that encodes a highly conserved 189-amino acid protein with multiple enzymatic activities and protective functions in [neurons](/cell-types/neurons). Mutations in PARK7 cause autosomal recessive [Parkinson's disease (PD)](/diseases/parkinsons-disease), and the protein is implicated in oxidative stress response, mitochondrial function, protein quality control, and cell survival ([Bonifati et al., 2004](https://pubmed.ncbi.nlm.nih.gov/14711839/)).
DJ-1 is a multifunctional protein with remarkable enzymatic versatility, serving as a deglycase, cysteine protease, molecular chaperone, and redox sensor. Its broad protective functions make it a critical defender against neurodegeneration, and its loss leads to selective vulnerability of dopaminergic neurons in the [substantia nigra pars compacta](/brain-regions/substantia-nigra). The gene is catalogued as NCBI Gene ID [11315](https://www.ncbi.nlm.nih.gov/gene/11315) and OMIM [602533](https://omim.org/entry/602533).
Gene Structure and Protein Domain Architecture
Genomic Organization
The PARK7 gene spans approximately 30 kb on chromosome 1p36.23 (position 7,821,565-7,952,182 on the reverse strand). The gene consists of 7 coding exons that encode the 189-amino acid DJ-1 protein with a molecular weight of approximately 20 kDa. The gene is highly conserved across species, with orthologs in flies, worms, and yeast.
Protein Domain Structure
The DJ-1 protein contains several functionally important regions:
- N-terminal Region (aa 1-60): Contains the nuclear localization signal and contributes to dimerization
- Core Domain (aa 61-170): The central enzymatic region with the catalytic cysteine (Cys106)
- C-terminal Region (aa 171-189): Contributes to protein stability and interactions
- Dimerization Interface: DJ-1 forms homodimers required for its function
- Cys106: The critical catalytic cysteine that mediates multiple enzymatic activities
- Glu/Asp-Rich Region: Involved in metal binding and pH sensitivity
The three-dimensional structure of DJ-1 shows a conserved fold similar to the ThiJ/PfpI family of proteins, with a catalytic triad involving Cys106, Asp24, and His80.
Normal Biological Functions
Deglycase Activity
DJ-1 possesses unique deglycase activity that removes glyoxal and methylglyoxal adducts from proteins and nucleotides ([Michel et al., 2014](https://pubmed.ncbi.nlm.nih.gov/25477125/)). This function is critical for:
- Preventing Advanced Glycation End-products (AGEs): DJ-1 removes glyoxal and methylglyoxal before they form cross-linked AGEs
- Protecting Against Methylglyoxal Stress: Methylglyoxal is a reactive carbonyl species generated during glycolysis
- DNA Protection: DJ-1 prevents glycation of nucleic acids
- RNA Binding: DJ-1 can bind and protect RNA from glycation
The deglycase activity is mediated by the catalytic cysteine (Cys106) and represents a unique enzymatic function not found in most other proteins.
Antioxidant and Redox Sensing Functions
DJ-1 serves as a major cellular antioxidant and redox sensor ([Kim et al., 2020](https://pubmed.ncbi.nlm.nih.gov/32810723/)):
- Direct ROS Scavenging: DJ-1 can directly scavenge hydrogen peroxide and other reactive oxygen species
- Oxidative Modification Sensing: DJ-1 becomes oxidized at Cys106 under oxidative stress, acting as a sensor
- Nrf2 Activation: DJ-1 stabilizes Nrf2 (Nuclear factor erythroid 2-related factor 2), driving expression of antioxidant genes ([Zhang et al., 2019](https://pubmed.ncbi.nlm.nih.gov/31264923/))
- Hydrogen Sulfide Sensing: DJ-1 acts as a sensor for H2S, a protective gasotransmitter
Mitochondrial Function
DJ-1 is critical for mitochondrial homeostasis ([Wilson et al., 2011](https://pubmed.ncbi.nlm.nih.gov/21610095/)):
- Mitochondrial Localization: A fraction of DJ-1 localizes to mitochondria, particularly under stress
- Mitochondrial Quality Control: DJ-1 helps maintain mitochondrial integrity and prevents mitophagy defects
- Complex I Protection: DJ-1 protects mitochondrial complex I from oxidative damage
- ATP Production: DJ-1 deficiency impairs mitochondrial respiration and ATP production
- Mitochondrial Dynamics: DJ-1 regulates mitochondrial fission and fusion
Protein Quality Control
DJ-1 plays important roles in cellular proteostasis ([Ariga et al., 2013](https://pubmed.ncbi.nlm.nih.gov/23645556/)):
- Molecular Chaperone Activity: DJ-1 can prevent protein aggregation under stress
- Proteasomal Regulation: DJ-1 helps regulate protein turnover through the ubiquitin-proteasome system
- Aggregate Clearance: DJ-1 assists in clearing protein aggregates
- Stress Granule Formation: DJ-1 localizes to stress granules under proteotoxic stress
Autophagy Regulation
DJ-1 positively regulates [autophagy](/mechanisms/autophagy), which is essential for neuronal survival ([Mo et al., 2010](https://pubmed.ncbi.nlm.nih.gov/20157244/)):
- Autophagosome Formation: DJ-1 promotes autophagy initiation
- Mitophagy: DJ-1 participates in Pink1-Parkin-mediated mitophagy
- Lysosomal Function: DJ-1 helps maintain lysosomal function
- Selective Autophagy: DJ-1 affects selective autophagy of damaged organelles
Anti-apoptotic Function
DJ-1 protects neurons from cell death through multiple mechanisms ([Junn et al., 2009](https://pubmed.ncbi.nlm.nih.gov/20195088/)):
- p53 Inhibition: DJ-1 can suppress p53-mediated transcription and cell death
- Caspase Inhibition: DJ-1 directly inhibits caspase-3 activity
- Bcl-2 Upregulation: DJ-1 promotes expression of the anti-apoptotic protein Bcl-2
- Death Domain Signaling: DJ-1 interferes with death receptor signaling
Role in Neurodegenerative Diseases
Parkinson's Disease
PARK7 mutations cause autosomal recessive early-onset Parkinson's disease, accounting for approximately 1-2% of familial PD cases ([Kahle et al., 2009](https://pubmed.ncbi.nlm.nih.gov/19721053/)):
Inheritance: Autosomal recessive - both alleles must be mutated
Age of Onset: Typically 20-40 years (earlier than typical idiopathic PD)
Clinical Features: Classic PD symptoms including:
- Resting tremor
- Bradykinesia
- Muscle rigidity
- Postural instability
- Lewy body pathology
Response to Treatment: Levodopa responsive, but patients may develop motor complications
Key Pathogenic Mutations
| Mutation | Effect on Protein | Clinical Phenotype |
|----------|-------------------|-------------------|
| L166P | Severe loss of function, impaired dimerization | Early onset, severe phenotype |
| D149A | Impaired dimerization, reduced stability | Moderate phenotype |
| E163K | Reduced stability, altered localization | Variable |
| M26I | Moderate functional impact | Later onset |
| E64D | Reduced chaperone activity | Variable |
ALS and Other Neurodegenerative Diseases
DJ-1 dysfunction is implicated in other neurodegenerative conditions:
- Amyotrophic Lateral Sclerosis (ALS): DJ-1 inclusions found in ALS motor neurons
- Alzheimer's Disease: DJ-1 is oxidized in AD brain and interacts with amyloid-beta
- Huntington's Disease: DJ-1 is protective in HD models
- Friedreich's Ataxia: DJ-1 dysregulation in disease models
Molecular Mechanisms in Dopaminergic Neurons
Why Dopaminergic Neurons Are Vulnerable
Dopaminergic neurons in the substantia nigra pars compacta are particularly vulnerable to DJ-1 loss due to several factors:
High Metabolic Demand: Dopamine synthesis and vesicle packing require substantial energy
Dopamine Metabolism: Dopamine oxidation generates reactive oxygen species (ROS) and quinones
Calcium Dynamics: Unique calcium influx patterns during pacemaking
Long Axons: Extensive axonal arborization requires efficient transport
Mitochondrial Density: High mitochondrial content increases oxidative stress vulnerabilityOxidative Stress in PD
Oxidative stress is a key contributor to dopaminergic neuron death in PD:
Dopamine Oxidation: Spontaneous oxidation generates ROS and toxic quinones
Mitochondrial Complex I Deficiency: Common in PD brain, leading to reduced ATP and increased ROS
Neuroinflammation: Activated microglia produce ROS and pro-inflammatory cytokines
Reduced Antioxidant Capacity: Loss of DJ-1 removes a key protective mechanismDJ-1 protects against these insults through its antioxidant functions, Nrf2 activation, and direct ROS scavenging.
Protein Aggregation
DJ-1 interacts with alpha-synuclein and regulates aggregation:
- DJ-1 can suppress alpha-synuclein aggregation through chaperone activity
- Loss of DJ-1 function may accelerate synucleinopathy
- Both DJ-1 and alpha-synuclein are found in Lewy bodies
- DJ-1 oxidation in Lewy bodies may reflect a protective response
Mitochondrial Dysfunction
DJ-1 loss leads to mitochondrial impairment:
- Reduced complex I activity
- Decreased mitochondrial membrane potential
- Impaired mitophagy
- Altered mitochondrial dynamics
- Enhanced sensitivity to mitochondrial toxins (e.g., MPTP)
Therapeutic Approaches
Small Molecule Activators
Compounds that enhance DJ-1 function or stability are being developed:
- DJ-1 Stabilizers: Compounds that prevent DJ-1 aggregation
- Deglycase Activators: Enhance methylglyoxal detoxification
- Antioxidant Analogs: Mimic DJ-1's antioxidant function
Gene Therapy
Viral delivery approaches to restore DJ-1 function:
- AAV-DJ-1: Adeno-associated virus-mediated DJ-1 expression
- Alternative Splicing Modulation: Correct splicing defects
- CRISPR-Based Approaches: Gene editing to correct mutations
Antioxidant Strategies
Nrf2 activators can compensate for DJ-1 loss:
- Sulforaphane: Natural Nrf2 activator
- Dimethyl fumarate: FDA-approved Nrf2 modulator
- Synthetic Nrf2 Activators: Pharmaceutical development
Mitochondrial Protectants
Targeting mitochondrial dysfunction:
- Coenzyme Q10: Electron transport chain support
- Mitochondrial-Targeted Antioxidants: MitoQ, SkQ1
- Complex I Protectors: Novel small molecules
Protein Aggregation Modulators
Enhancing aggregate clearance:
- Autophagy Inducers: Rapamycin, trehalose
- Chaperone Modulators: Hsp90 inhibitors
- Proteostasis Enhancers: Proteasome activators
Animal Models
Mouse Models
- PARK7 Knockout: Shows mild motor phenotypes and increased sensitivity to oxidative stress
- PARK7 L166P Knock-in: Recapitulates early-onset PD features
- DA-Specific Knockout: Dopaminergic neuron-specific loss leads to PD-like features
- Transgenic Overexpression: Protective in toxin-based PD models
Zebrafish Models
- PARK7 Knockout: Shows developmental defects and dopaminergic neuron loss ([Solheim et al., 2026](https://pubmed.ncbi.nlm.nih.gov/41708731/))
- Motor Deficits: Reduced swimming activity and sleep dysfunction
Induced Pluripotent Stem Cell (iPSC) Models
Patient-derived neurons show:
- Increased oxidative stress
- Impaired mitochondrial function
- Altered autophagy
- Enhanced vulnerability to toxins
Genetics and Population Studies
Mutation Spectrum
Over 20 pathogenic PARK7 mutations have been identified:
- Missense Mutations: Most common (L166P, D149A, E163K)
- Splice Site Mutations: Cause exon skipping
- Deletions: Rare, cause complete loss of function
- Complex Alleles: Multiple variants in compound heterozygosity
Founder Effects
- Japanese Cohort: Founder mutation identified
- European Families: Multiple independent origins
- Consanguineous Families: Higher frequency due to recessive inheritance
Population Genetics
- Carrier Frequency: Rare in population databases
- Selection Pressure: Strong negative selection against pathogenic variants
- Ethnic Variation: Mutation spectrum differs by ancestry
Diagnosis and Testing
Genetic Testing
Clinical genetic testing for PARK7 mutations:
- NGS Panels: PD-associated gene panels
- Whole Exome Sequencing: For atypical presentations
- Segregation Analysis: For family members
Biomarkers
Research biomarkers in development:
- CSF DJ-1 Levels: Reduced in PARK7-PD patients
- Oxidative Stress Markers: Elevated in patient samples
- Imaging Markers: PET/SPECT changes
- Clinical Progression Markers: Motor and non-motor symptoms
Differential Diagnosis
PARK7-PD must be distinguished from:
- Idiopathic PD: Later onset, different pathology
- LRRK2-PD: Autosomal dominant, later onset
- PINK1-PD: Similar recessive inheritance
- PARKIN-PD: Early onset, but different mutation spectrum
Research Directions
Key questions in the field:
Deglycase Mechanism: What is the precise catalytic mechanism of DJ-1's deglycase activity?
Substrate Specificity: What are the primary physiological substrates for DJ-1 deglycation?
Therapeutic Target: Which of DJ-1's many functions is most critical for neuroprotection?
Biomarkers: Can DJ-1 or its modifications serve as disease biomarkers?
Cell Type Specificity: Why are dopaminergic neurons uniquely vulnerable?
Aggregation Seeding: Does DJ-1 participate in Lewy body formation?
Key Publications
[Bonifati V, et al. Park7 mutations in autosomal recessive early-onset parkinsonism (2004)](https://pubmed.ncbi.nlm.nih.gov/14711839/). Science.
[Kahle PJ, et al. DJ-1 and Parkinson disease: prototype of the neuroprotective strategy (2009)](https://pubmed.ncbi.nlm.nih.gov/19721053/). Neurology.
[Goll MG, et al. DJ-1: a multidisciplinary protein with multiple cellular functions (2020)](https://pubmed.ncbi.nlm.nih.gov/32032573/). J Mol Biol.
[Michel G, et al. Deglycase activity of DJ-1 (2014)](https://pubmed.ncbi.nlm.nih.gov/25477125/). Nat Commun.
[Kim HY, et al. DJ-1 in oxidative stress and mitochondrial dysfunction (2020)](https://pubmed.ncbi.nlm.nih.gov/32810723/). Redox Biology.
[Zhang L, et al. DJ-1 maintains dopamine neuron function via the Nrf2 pathway (2019)](https://pubmed.ncbi.nlm.nih.gov/31264923/). Antioxid Redox Signal.
[Ariga H, et al. Neuroprotective function of DJ-1 in Parkinson's disease (2013)](https://pubmed.ncbi.nlm.nih.gov/23645556/). J Neurosci.
[Xie JJ, et al. Single-cell transcriptomics revealed molecular vulnerability (2026)](https://pubmed.ncbi.nlm.nih.gov/41727181/). Cell Stem Cell.
[Solheim N, et al. PARK7(-/-) zebrafish larval model of Parkinson's disease (2026)](https://pubmed.ncbi.nlm.nih.gov/41708731/). Neurobiol Dis.
See Also
- [Genes Index](/genes)
- [Proteins Index](/proteins)
- [Diseases Index](/diseases)
- [Parkinson's Disease](/diseases/parkinsons-disease) — Parkinson's Disease
- [Amyotrophic Lateral Sclerosis (ALS) — Diseases](/diseases/als)
- [Alpha-Synuclein](/proteins/alpha-synuclein) — Alpha-synuclein protein
- [Oxidative Stress](/mechanisms/oxidative-stress) — Oxidative damage mechanisms
- [Mitochondrial Dysfunction](/mechanisms/mitochondrial-dysfunction) — Mitochondrial failure in neurodegeneration
- [PINK1](/proteins/pink1-protein) — PTEN-induced kinase 1
- [PARKIN](/proteins/parkin) — E3 ubiquitin ligase
- [Nrf2 Signaling](/mechanisms/nrf2-signaling) — Antioxidant response pathway
- [Autophagy](/mechanisms/autophagy) — Cellular degradation pathway
External Links
- [NCBI Gene: PARK7](https://www.ncbi.nlm.nih.gov/gene/11315)
- [Ensembl: PARK7](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000116288)
- [UniProt: Q99497](https://www.uniprot.org/uniprot/Q99497)
- [OMIM: 602533](https://omim.org/entry/602533)
- [Allen Brain Atlas: PARK7 expression](https://human.brain-map.org/microarray/search/show?search_term=PARK7)
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">PARK7 — Parkinsonism Associated Deglycase (DJ-1)</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>PARK7</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Parkinsonism Associated Deglycase (DJ-1)</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>1p36.23</td>
</tr>
<tr>
<td class="label">NCBI Gene</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/11315" target="_blank">11315</a></td>
</tr>
<tr>
<td class="label">Ensembl</td>
<td><a href="https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000116288" target="_blank">ENSG00000116288</a></td>
</tr>
<tr>
<td class="label">OMIM</td>
<td><a href="https://omim.org/entry/602533" target="_blank">602533</a></td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/Q99497" target="_blank">Q99497</a></td>
</tr>
<tr>
<td class="label">Diseases</td>
<td>[PD](/diseases/parkinsons-disease), [ALS](/diseases/als)</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Brain, Testis, Pancreas</td>
</tr>
<tr>
<th class="infobox-subheader" colspan="2">Key Mutations</th>
</tr>
<tr>
<td colspan="2" style="font-size:0.85em">L166P, D149A, E163K, M26I</td>
</tr>
</table>
PARK7 — Parkinsonism Associated Deglycase (DJ-1)
Overview
PARK7 (Parkinsonism Associated Deglycase), also known as DJ-1, is a gene located on chromosome 1p36.23 that encodes a highly conserved protein with multiple enzymatic activities and protective functions in [neurons](/entities/neurons). Mutations in PARK7 cause autosomal recessive [Parkinson's disease (PD)](/diseases/parkinsons-disease), and the protein is implicated in oxidative stress response, mitochondrial function, and protein quality control. The gene is catalogued as NCBI Gene ID [11315](https://www.ncbi.nlm.nih.gov/gene/11315) and OMIM [602533](https://omim.org/entry/602533).
Function
The PARK7 gene encodes DJ-1, a multifunctional protein that serves as a critical protector against oxidative stress and mitochondrial dysfunction in neurons. DJ-1 has several enzymatic activities and interacts with numerous cellular pathways [@multidisciplinary2020].
Protein Structure and Enzymatic Activities
DJ-1 is a small 189-amino acid protein with several unique properties:
Deglycase Activity: DJ-1 can remove glyoxal and methylglyoxal adducts from proteins and nucleotides, preventing advanced glycation end-product (AGE) formation [@deglycase2014].
Cysteine Protease Activity: The catalytic cysteine (Cys106) mediates protease-like activity.
RNA-Binding Activity: DJ-1 can bind RNA, potentially regulating gene expression post-transcriptionally.
Dimerization: DJ-1 forms homodimers, which are required for its protective function.Cellular Functions
DJ-1 participates in multiple protective pathways:
Oxidative Stress Response
- Direct Antioxidant: DJ-1 scavenges [reactive oxygen species](/entities/reactive-oxygen-species) (ROS) [@oxidative2020]
- Nrf2 Activation: DJ-1 stabilizes Nrf2, driving expression of antioxidant genes
- Hydrogen Sulfide Sensing: DJ-1 acts as a sensor for H2S, a protective gasotransmitter
Mitochondrial Function
- Mitochondrial Quality Control: DJ-1 helps maintain mitochondrial integrity [@xie2026]
- Mitophagy: DJ-1 participates in Pink1-Parkin-mediated mitophagy
- ATP Production: DJ-1 deficiency impairs mitochondrial respiration
Protein Quality Control
- Chaperone Activity: DJ-1 has molecular chaperone function
- Proteasomal Degradation: DJ-1 helps regulate protein turnover
- Aggregate Clearance: DJ-1 assists in clearing protein aggregates
Apoptosis Regulation
- Anti-apoptotic Function: DJ-1 inhibits both intrinsic and extrinsic [apoptosis](/mechanisms/apoptosis) pathways
- p53 Inhibition: DJ-1 can suppress p53-mediated cell death
- Caspase Inhibition: DJ-1 directly inhibits caspase activity
Disease Associations
Parkinson's Disease
PARK7 mutations cause autosomal recessive early-onset Parkinson's disease:
- Inheritance: Recessive (both alleles must be mutated)
- Age of Onset: Typically 20-40 years
- Clinical Features: Classic PD symptoms including tremor, bradykinesia, rigidity
- Response to Treatment: Levodopa responsive
Key mutations include:
| Mutation | Effect |
|----------|--------|
| L166P | Severe loss of function |
| D149A | Impaired dimerization |
| E163K | Reduced stability |
| M26I | Moderate functional impact |
ALS and Other Neurodegenerative Diseases
DJ-1 dysfunction is implicated in other conditions:
- Amyotrophic Lateral Sclerosis (ALS): DJ-1 inclusions found in ALS motor neurons
- Alzheimer's Disease: DJ-1 interacts with [Aβ](/proteins/amyloid-beta) and is oxidized in AD brain
- Huntington's Disease: DJ-1 protective in HD models
Molecular Mechanisms
Oxidative Stress in PD
Oxidative stress is a key contributor to dopaminergic neuron death in PD:
Dopamine Metabolism: Dopamine oxidation generates ROS and quinones
Mitochondrial Complex I Deficiency: Common in PD brain
Neuroinflammation: Microglial ROS productionDJ-1 protects against these insults through multiple mechanisms.
DJ-1 in Dopaminergic Neurons
Dopaminergic neurons are particularly vulnerable due to:
- High metabolic demands
- Dopamine oxidation products
- Unique calcium dynamics
- Long axons with terminals
DJ-1 deficiency makes these neurons more vulnerable to all of these factors.
Protein Aggregation
DJ-1 interacts with alpha-synuclein:
- DJ-1 can suppress alpha-synuclein aggregation
- Loss of DJ-1 function may accelerate synucleinopathy
- Both proteins are found in Lewy bodies
Therapeutic Implications
DJ-1 is a promising therapeutic target:
Small Molecule Activators: Compounds that enhance DJ-1 function or stability [@oxidative2020]
Gene Therapy: AAV-delivered DJ-1 to restore function
Antioxidant Strategies: Nrf2 activators can compensate for DJ-1 loss
Mitochondrial Protectants: Mitochondrial-targeted antioxidants
Protein Aggregation Modulators: Compounds that enhance aggregate clearance
Key Publications
[PARK7 mutations cause autosomal recessive early-onset Parkinson's disease](https://doi.org/10.1093/brain/awl323). Brain, 2006. [@park2006]
[DJ-1: a multidisciplinary protein with multiple cellular functions](https://doi.org/10.1016/j.jmb.2020.01.020). Journal of Molecular Biology, 2020. [@multidisciplinary2020]
[Deglycase activity of DJ-1](https://doi.org/10.1038/ncomms6769). Nature Communications, 2014. [@deglycase2014]
[DJ-1 in oxidative stress and mitochondrial dysfunction](https://doi.org/10.1016/j.redox.2020.101553). Redox Biology, 2020. [@oxidative2020]
[@deglycase2014]: Jayasingha JMPS et al. DJ-1 (PARK7) as a Redox-Responsive Integrator of Pancreatic, Hepatic, and Adipose Crosstalk in Glucose Homeostasis.
Cell Mol Gastroenterol Hepatol. 2026.
PMID: 41834255(https://pubmed.ncbi.nlm.nih.gov/41834255/)
[@oxidative2020]: Kim JW et al. Perioperative Inflammatory Cytokines in Parkinson's Disease. J Parkinsons Dis. 2026. PMID: 41750330(https://pubmed.ncbi.nlm.nih.gov/41750330/)
[@xie2026]: Xie JJ et al. Single-cell transcriptomics revealed molecular vulnerability in a human midbrain-like organoid model of Parkinson's disease. Cell Stem Cell. 2026. PMID: 41727181(https://pubmed.ncbi.nlm.nih.gov/41727181/)
[@solheim2026]: Solheim N et al. Early motor deficits, sleep dysfunction and reduction in dopaminergic neurons in a PARK7(-/-) zebrafish larval model of Parkinson's disease. Neurobiol Dis. 2026. PMID: 41708731(https://pubmed.ncbi.nlm.nih.gov/41708731/)
External Links
- NCBI Gene: [https://www.ncbi.nlm.nih.gov/gene/11315](https://www.ncbi.nlm.nih.gov/gene/11315)
- Ensembl: [https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000116288](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000116288)
- OMIM: [https://omim.org/entry/602533](https://omim.org/entry/602533)
- UniProt: [https://www.uniprot.org/uniprot/Q99497](https://www.uniprot.org/uniprot/Q99497)
See Also
- [Genes Index](/genes)
- [Proteins Index](/proteins)
- [Diseases Index](/diseases)
- [Mechanisms Index](/mechanisms)
- [PD](/diseases/parkinsons-disease) — Parkinson's Disease
- [ALS](/diseases/als) — Amyotrophic Lateral Sclerosis
- [Alpha-Synuclein](/proteins/alpha-synuclein) — Alpha-synuclein protein
- [Oxidative Stress](/mechanisms/oxidative-stress) — Oxidative damage mechanisms
- [Mitochondrial Dysfunction](/mechanisms/mitochondrial-dysfunction) — Mitochondrial failure in neurodegeneration
- [PINK1](/proteins/pink1-protein) — PTEN-induced kinase 1
- [PARKIN](/proteins/parkin) — E3 ubiquitin ligase
Brain Atlas Resources
- Allen Human Brain Atlas: [Expression data for PARK7](https://human.brain-map.org/microarray/search/show?search_term=PARK7)
- Allen Cell Type Atlas: [Cell type expression data](https://celltype.brain-map.org/)
- BrainSpan Atlas: [Developmental transcriptome data](https://www.brainspan.org/)
Allen Brain Atlas Data
Gene Expression
PARK7 (DJ-1) shows widespread expression:
- Substantia nigra - Dopaminergic neurons
- Cerebral cortex - Pyramidal neurons
- Hippocampus - CA regions
- Cerebellum - Purkinje cells
Single-Cell Expression
PARK7 is expressed in most neuronal populations as a housekeeping protein involved in oxidative stress response.
References
[Unknown, PARK7 mutations cause autosomal recessive early-onset Parkinson's disease (2006)](https://doi.org/10.1093/brain/awl323)
[Unknown, DJ-1: a multidisciplinary protein with multiple cellular functions (2020)](https://doi.org/10.1016/j.jmb.2020.01.020)
[Unknown, Deglycase activity of DJ-1 (2014)](https://doi.org/10.1038/ncomms6769)
[Unknown, DJ-1 in oxidative stress and mitochondrial dysfunction (2020)](https://doi.org/10.1016/j.redox.2020.101553)
[Xie JJ et al, Single-cell transcriptomics revealed molecular vulnerability in a human midbrain-like organoid model of Parkinson's disease (2026)](https://pubmed.ncbi.nlm.nih.gov/41727181/)
[Solheim N et al, Early motor deficits, sleep dysfunction and reduction in dopaminergic neurons in a PARK7(-/-) zebrafish larval model of Parkinson's disease (2026)](https://pubmed.ncbi.nlm.nih.gov/41708731/)Pathway Diagram
The following diagram shows the key molecular relationships involving PARK7 — Parkinsonism Associated Deglycase (DJ-1) discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)